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ABSTRACT
Introduction: Chlamydia trachomatis (CT) is the most prevalent sexually transmitted 
bacterial infection, affecting mainly young, sexually active women. Untreated infection 
may lead to reproductive complications due to tubal damage. Infections during 
pregnancy may cause preterm labor, low birth weight, perinatal death, and neonatal 
conjunctivitis and pneumonia. There are few data on CT infection in Brazil. The aim 
of this study was to determine CT prevalence in infertile and pregnant women.
Methods: A cross-sectional study included 77 infertile and 60 asymptomatic 
pregnant women. First-void urine was tested for CT using PCR (Polymerase Chain 
Reaction). Blood samples were collected for CT IgG antibodies testing using indirect 
immunofluorescence. A questionnaire about medical, gynecological, and sexual history 
was completed by all participants.
Results: We found statistically similar prevalence of PCR and IgG antibodies between 
the groups. There was a 61% prevalence of CT IgG antibodies in infertile women and 
56.7% in pregnant women. PCR was positive in only one (1.3%) infertile woman and 
in none pregnant women.
Conclusion: There is a high prevalence of CT IgG antibody in Brazilian pregnant and 
infertile women, but we found a low prevalence of positive PCR in the urine samples. 
CT antibodies were associated with sexual behavior and smoking.
Keywords: Chlamydia trachomatis; Chlamydia infections; prevalence; nucleic acid 
amplification techniques; infertility; female; fluorescent antibody technique.
http://seer.ufrgs.br/hcpaClin Biomed Res 2016;36(3)118
Gomez et al.
Chlamydia trachomatis (CT) is the most prevalent 
sexually transmitted bacterial infection1. According to the 
World Health Organization (WHO), 131 million people 
were infected worldwide in 20122. It affects mainly 
young, sexually active women3. Most infections with 
CT are asymptomatic4. In women, untreated infection 
may lead to pelvic inflammatory disease (PID) with 
the risk of serious reproductive complications, such 
as chronic pelvic pain, tubal factor infertility (TFI), and 
ectopic pregnancy5. Studies suggest that chlamydial 
infection in pregnant women can enhance the risk of 
preterm labor, low birth weight, and perinatal death6. 
Additionally, CT vertical transmission usually causes 
neonatal inclusion conjunctivitis and/or pneumonia7.
Among various methods available for CT infection 
diagnosis, nucleic acid amplification tests (NAATs) 
are preferable due to their high sensibility and 
specificity and because they can be performed using 
non-invasive samples, such as urine and vaginal 
swabs8. Chlamydia immunoglobulin (Ig) G antibodies 
persist for years even after antibiotic treatment and 
are used as markers of a past infiltrating CT infection9.
In Brazil, since routine screening is not recommended 
by the public health system, there are few data on CT 
infection. The purpose of this study was to estimate 
the prevalence of CT infection in infertile and pregnant 
women seen at a public hospital in Southern Brazil.
METHODS
Subjects
A cross-sectional study in infertile and pregnant 
women seen at Hospital de Clínicas de Porto Alegre 
(HCPA) was conducted from January to December 
2015. Participants were divided in two groups. 
The infertile group (n=77) included women being 
treated at the infertility outpatient clinic of HCPA. 
They were unable to conceive after 1 year of regular 
unprotected sexual intercourse. The pregnant group 
(n=60) included pregnant asymptomatic women of 
any gestational age. Exclusion criteria were similar for 
both groups: acute symptoms of PID, use of antibiotics 
during the last 30 days, age under 18 years old, and 
refusal to participate in the study. First-void urine 
(FVU) for CT “in house” Polymerase Chain Reaction 
(PCR) test and a single venous blood sample for 
indirect immunofluorescence (IIF) for CT serological 
testing were collected from all participating women. 
Additionally, all women answered a questionnaire 
about their sexual and gynecological medical history.
Laboratory Methods
Antibody testing was performed by IIF in blood 
samples at the Hospital de Clínicas de Porto Alegre 
laboratory. The commercial kit Viro-Immun (VIRO-IMMUN 
Labor-Diagnostika GmbH Oberursel /Germany) 
was used. FVU samples were immediately shipped 
to Amplicon laboratory, and PCR was performed 
using an “in house” method developed according 
to previous studies10,11.
Ethical Aspects
The study was approved by the Research Ethics 
Committee of the Hospital de Clínicas de Porto 
Alegre, and all patients were informed about this 
study through the informed consent form.
Statistical Analysis
The sample size was calculated using the WinPEPI 
program (Programs for Epidemiologists for Windows) 
11.43 version and was based on previous findings of 
IgG prevalence (39% in infertile women and 19% in 
pregnant women)12. Considering a 95% confidence 
interval and a statistical power of 71.6%, we included 
n=77 infertile and n=60 pregnant participants. Data 
processing and analyses were performed using the 
SPSS 21.0 (SPSS, Chicago, Ill, USA). Initially, a 
descriptive analysis of the main characteristics of the 
participants and their related risk factors was performed. 
Quantitative variables were expressed as mean and 
standard deviation (mean±SD) or median value and 
interquartile amplitude (median±IQ). Categorical 
variables were expressed as absolute and relative 
frequencies. We used the t-student test to compare 
quantitative variables. The Mann-Whitney U test 
was used when data distribution was asymmetrical. 
Pearson’s chi-squared test or Fisher’s exact test 
were applied to sets of categorical data. We also 
calculated IgG’s sensitivity, specificity, positive and 
negative predictive value, the accuracy and the 
odds ratio to predict TFI. P ≤ 0.05 was considered 
statistically significant.
RESULTS
FVU and serum samples of 60 healthy pregnant 
women and 77 infertile women were investigated. 
Pregnant women were younger and had lower rates 
of steady sexual partner, previous PID, and previous 
pelvic surgery than the infertile group. They also had 
higher rates of regular condom use. The characteristics 
of the sample are summarized in Table 1. The mean 
gestational age was 30.6 weeks (± 7.4) among 
pregnant women. In the infertile group, median time 
of infertility was 6 years (3-10). Primary infertility 
was found in 84.4% of women and 54% of them 
had tubal damage. Sixteen women (20.8%) suffered 
from more than one cause of infertility (table 2). 
We found statistically similar prevalence rates of PCR 
and IgG antibodies between the groups. However, 
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infertile women had higher median of IgG titration 
(table 3). When we compared the TFI subgroup with 
controls, there were statistically more individuals 
with high titration (IgG≥128) levels among infertile 
women (table 4). Sensitivity, specificity, positive 
predictive value (PPV), negative predictive value 
(NPV), accuracy, and odds ratio were calculated 
concerning IgG’s ability to predict tubal damage 
(table 5). We found association between positive IgG 
antibody test and higher number of sexual partners 
in life (table 6). IgG high titration level (IgG≥128) 
was associated with younger age of first sexual 
intercourse, higher number of sexual partners and 
smoking (table 7). Individuals with TFI were more 
likely to have previous history of PID than women 
with other causes of infertility (table 8).
Table 1: Sample characteristics.
Variables Infertile (n=77) Pregnant (n=60) p
Age (years) – mean±SD 32.8 ± 4.4 27.1 ± 6.4 <0.001
Number of pregnancies – median (P25 – P75) 0 (0-1) 2 (1-3) <0.001
Previous abortion – n(%) 20 (26.0) 13 (21.7) 0.701
Age of first sexual intercourse (years) – mean±SD 16.4 ± 2.3 16.3 ± 1.9 0.710
Number of sexual partners – median (P25 – P75) 3 (1-4.5) 3 (2-5) 0.488
Steady sexual partner – n(%) 77 (100) 55 (91.7) 0.015
Regular condom use – n(%) 4 (5.2) 15 (25.0) 0.002
Previous PID – n(%) 25 (32.5) 2 (3.3) <0.001
Previous ectopic pregnancy – n(%) 7 (9.1) 1 (1.7) 0.079
Previous pelvic surgery – n(%) 33 (42.9) 3 (5.0) <0.001
Previous HPV infection – n(%) 12 (15.6) 4 (6.7) 0.179
Smoking – n(%) 10 (13.0) 4 (6.7) 0.354
SD = standard deviation; PID = pelvic inflammatory disease; HPV = human papilloma virus.
Table 2: Characteristics of the infertile group.
Variables Infertile (n=77)
Previous empirical treatment – n(%) 33 (42.9)
Primary infertility – n(%) 65 (84.4)
Time of infertility (years) – median (P25 – P75) 6 (3-10)
Causes of infertility – n(%)
Tubal damage 42 (54.5)





Multiple causes – n(%) 16 (20.8)
Table 3: Prevalence of CT IgG and PCR in groups.
CT test Infertile (n=77) Pregnant (n=60) p
IgG- n(%) 0.733
Positive 47 (61.0) 34 (56.7)
Negative 30 (39.0) 26 (43.3)
IgG titration– median (P25 -P75) 256 (128-512) 128 (64-256) 0.016
IgG ≥128 – n(%) 39 (50.6) 19 (31.7) 0.040
PCR 1.000
Positive 1 (1.3) 0 (0.0)
Negative 76 (98.7) 60 (100)
IgG = immunoglobulin G; PCR = Polymerase Chain Reaction.
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Table 4: Prevalence of CT IgG and PCR in the tubal factor infertility subgroup and in pregnant women.
CT test TFI infertility (n=42) Pregnant (n=60) p
IgG 0.571
Positive 27 (64.3) 34 (56.7)
Negative 15 (35.7) 26 (43.3)
IgG titration – median (P25 – P75) 256 (128-512) 128 (64-256) 0.002
IgG ≥128 – n(%) 26 (61.9) 19 (31.7) 0.005
PCR -
Positive 0 (0.0) 0 (0.0)
Negative 42 (100) 60 (100)
TFI = tubal factor infertility; IgG = immunoglobulin G; PCR = Polymerase Chain Reaction.
Table 5: IgG diagnostic properties in predicting tubal damage.
Diagnostic properties Positive (>0) IgG ≥ 128 IgG ≥ 256
Sensitivity 64.3% 61.9% 47.6%
Specificity 42.9% 62.9% 71.4%
PPV 57.4% 66.7% 66.7%
NPV 50.0% 57.9% 53.2%
Accuracy 54.5% 62.3% 58.4%
Odds ratio 1.35 2.75 2.27
PPV = positive predictive value; NPV = negative predictive value.
Table 6: Association between participants’ characteristics and IgG positivity.
Variables* IgG Positive (IgG >0)(n=81)
IgG Negative (IgG=0)
(n=56) p
Age 30.6 ± 5.7 29.8 ± 6.5 0.423
Age of first sexual intercourse 16.1 ± 2.1 16.8 ± 2.0 0.060
Number of sexual partners 3 (2-5) 2 (1-4) 0.036
Steady sexual partner 77 (95.1) 55 (98.2) 0.648
Condom use 13 (16.0) 6 (10.7) 0.524
Previous PID 17 (21.0) 10 (17.9) 0.815
Previous ectopic pregnancy 6 (7.4) 2 (3,6) 0.471
Previous pelvic surgery 26 (32.1) 10 (17.9) 0.096
Previous HPV infection 11 (13.6) 5 (8.9) 0.574
Smoking 11 (13.6) 3 (5.4) 0.202
Number of pregnancies 1 (0-2) 1 (0-2) 0.186
* Expressed as mean±SD, median (percentile 25-75) or n(%). PID = pelvic inflammatory disease; HPV = human papilloma virus.
Table 7: Association between participants’ characteristics and IgG titration.
Variables*







Age 30.5 ± 5.3 30.1 ± 6.6 0.743
Age of first sexual intercourse 15.7 ± 1.9 16.8 ± 2.2 0.002
Number of sexual partners 3.5 (2-7) 2 (1-4) 0.007
Steady sexual partner 54 (93.1) 78 (98.7) 0.162
Condom use 10 (17.2) 9 (11.4) 0.466
Previous PID 15 (25.9) 12 (15.2) 0.182
Previous ectopic pregnancy 6 (10.3) 2 (2.5) 0.071
Previous pelvic surgery 20 (34.5) 16 (20.3) 0.094
Previous HPV infection 8 (13.8) 8 (10.1) 0.696
Smoking 10 (17.2) 4 (5.1) 0.041
Number of pregnancies 1 (0-2) 1 (0-2) 0.912
* Expressed as mean±SD, median (percentile 25-75) or n (%). PID = pelvic inflammatory disease; HPV = human papilloma virus.
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DISCUSSION
Using different diagnostic methods, we found no 
significant differences between fertile and infertile 
women for CT infection. This study found a 61% 
prevalence of CT IgG antibodies in infertile women 
and 56.7% in pregnant women. A study conducted in 
India13 found a 68% prevalence of CT IgG antibodies 
in infertile women and 10% in healthy pregnant 
women. Siemer et al.12 also showed statistically 
different prevalence rates of CT IgG between infertile 
and pregnant women (39% vs. 19%, respectively). 
Rashidi et al.14, using ELISA to test IgG antibodies, 
observed lower rates of seroprevalence and found 
no difference between infertile and pregnant women 
(9% vs. 5%, respectively). In our study, the high 
prevalence of CT antibodies in pregnant women may 
be caused by cross-reaction with C. pneumoniae, 
because most serological tests are not species-
specific tests.
PCR in FVU was positive in only one (1.3%) infertile 
woman and in none of the pregnant participants. 
Previous studies in Brazil have found variable 
prevalence rates of CT using NAATs. Ramos et al.15 
tested 161 women between 15 and 44 years old in 
Porto Alegre-RS and found a 0.59% CT prevalence 
in urine samples. Two multicenter studies were 
conducted in Brazil to estimate CT prevalence in 
pregnancy and found a 9.8% prevalence when FVU 
was used to perform PCR analysis, whereas a 9.4% 
prevalence was found when hybrid capture was 
performed in endocervical swabs16,17.
Some authors believe that CT IgG antibodies 
are as accurate as hysterosalpingography (HSG) 
in predicting TFI18. In our study, IgG titration of 
128 had better diagnostic properties in predicting 
tubal damage. Nevertheless, our findings regarding 
Table 8: Association between participants’ characteristics and tubal factor infertility.
Variables* Tubal factor infertility(n=42)




Age 32.7 ± 4.1 32.9 ± 4.7 0.825
Number of pregnancies 0 (0-2) 0 (0-1) 0.094
Age of first sexual intercourse 16.2 ± 1.7 16.7 ± 2.8 0.347
Number of sexual partners 3 (1-5) 3 (1-4) 0.354
Condom use 2 (4.8) 2 (5.7) 1.000
Previous PID 22 (52.4) 3 (8.6) <0.001
Previous ectopic pregnancy 6 (14.3) 1 (2.9) 0.119
Previous pelvic surgery 20 (47.6) 13 (37.1) 0.488
Previous HPV infection 8 (19.0) 4 (11.4) 0.547
Smoking 5 (11.9) 5 (14.3) 1.000
* Expressed as mean±SD, median (percentile 25-75) or n (%). PID = pelvic inflammatory disease; HPV = human papilloma virus.
IgG were worse than previous studies. Malik et al.19 
found 72.7% sensitivity, 80% PPV, 77.7% specificity, 
and 70% NPV of IgG antibodies measured by ELISA. 
A meta-analysis performed in 2008 indicated that 
the predictive value of CT antibody test for tubal 
pathology is limited: its sensitivity varies between 
30% and 88%, whereas its specificity varies between 
45% and 100%20.
We found correlation between IgG presence and 
younger age of first sexual intercourse, higher number 
of sexual partners, and smoking. This finding agrees 
with previous studies. Datta et al.21 concluded that 
age under 25 years old, multiple sexual partners, 
irregular use of condom, and previous history of 
any sexual transmitted disease are risk factors for 
CT infection.
A limitation of our study is that pregnant women 
were tested mostly in the third quarter of pregnancy. 
Therefore, we could not differentiate infections 
that occurred previously or during pregnancy. 
Besides that, the low prevalence of positive PCR 
in infertile women could be explained by the 
fact that almost 43% of them had documented 
previous empirical treatment with azithromycin 
during infertility investigation. Furthermore, CT 
may persist in a viable and metabolically active 
state in the upper genital tract, despite negative 
PCR results in urine or endocervical samples22. 
In addition, we have to consider that the mean age 
in our study population was relatively high, and 
more than 91% of women in our population had a 
steady sexual partner. Because most CT infections 
occur in people younger than 25 years old who are 
sexually promiscuous, the high seroprevalence of 
CT and the low rates of positive PCR found in our 
study are understandable.
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In conclusion, we demonstrated a statistically 
similar high prevalence of CT IgG antibody in Brazilian 
pregnant and infertile women, but a low prevalence 
of positive PCR in urine samples. CT antibodies 
were associated with sexual behavior and smoking.
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